Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 4.35
Day High 4.38
Open:4.35
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Correvio Pharma Corp, formerly Cardiome Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are AGGRASTAT, EXEMBOL, BRINAVESS and others. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Correvio to Present at the 30th Annual Piper Jaffray Healthcare Conference
PR Newswire - Tue Nov 20, 6:00AM CST
PR Newswire - CMTX
Tue Nov 20, 6:00AM CST
NASDAQ: CORV TSX: CORV
Correvio to Participate In Upcoming Investor Conferences
PR Newswire - Thu Sep 20, 3:01PM CDT
PR Newswire - CMTX
Thu Sep 20, 3:01PM CDT
NASDAQ: CORV TSX: CORV
Correvio Reports Preliminary Data Collected from >2,000 Brinavess® Treatment Episodes in EU Post-Authorization Safety Study
- CNW Group - Wed Sep 5, 6:00AM CDT
CNW Group - CMTX
Wed Sep 5, 6:00AM CDT
NASDAQ: CORVTSX: CORV
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 4.27 +1.87% increase
on 12/18/18
Period Open:4.29
Price movement based on the high, low and last over the given period.
5.06 -14.03% decrease
on 12/12/18
+0.06 (+1.40%) increase
since 11/19/18
3-Month 3.75 +16.00% increase
on 11/14/18
Period Open:5.67
Price movement based on the high, low and last over the given period.
5.69 -23.55% decrease
on 09/20/18
-1.32 (-23.28%) decrease
since 09/19/18
52-Week 1.65 +163.64% increase
on 02/05/18
Period Open:1.93
Price movement based on the high, low and last over the given period.
6.90 -36.96% decrease
on 08/17/18
+2.42 (+125.39%) increase
since 12/19/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement